Juno Therapeutics Investor
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Technology:
CAR-T, Cell_Therapies
Industry:
CAR-T
Headquarters:
Seattle, Washington, United States
Founded Date:
2013-01-01
Employees Number:
251-500
Funding Status:
M&A
Number Of Exits:
2
Investors Number:
4
Total Funding:
310000000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2014-08-05
Last Funding Type:
Series B
Register and Claim Ownership